Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

5 recruiting1 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 1

2(33.3%)

6Total

N/A(4)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05292664Phase 1Recruiting

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Role: collaborator

NCT06283251Not ApplicableRecruiting

PediRISE Feasibility

Role: collaborator

NCT06941324Not ApplicableRecruiting

Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors

Role: collaborator

NCT07007117Phase 1Recruiting

PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma

Role: collaborator

NCT06185686Recruiting

Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients

Role: collaborator

NCT04863157Not ApplicableCompleted

Survivor-Sleep Health Information Program

Role: collaborator

NCT01100658Not ApplicableTerminated

Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors

Role: collaborator

All 7 trials loaded